 Itamar Medical Ltd. Nasdaq: ITMR ITMR, a medical technology company focused on the development and commercialization of non-invasive medical devices to aid in the diagnosis of respiratory sleep disorders, today announced that it has entered into a research collaboration agreement with Clalit Research Institute CRI, a subsidiary of Clalit Health Services CHS, Israels largest state-mandated health service organization. Under the agreement, Itamar and CRI will collaborate to conduct a study designed to determine if data from the WatchPAT signal can help predict cardiovascular health outcomes. The study will use artificial intelligence tools to compare predictive models for different outcomes, such as cardiovascular disease, atrial fibrillation, congestive heart failure and other outcomes. 